Cargando…
Total intravenous anesthesia induced and maintained by a combination of remimazolam and remifentanil without a neuromuscular blocking agent: a prospective, observational pilot study
BACKGROUND: A novel short-acting benzodiazepine, Remimazolam, has recently been approved for general anesthesia and sedation. Hence, we investigated the feasibility and safety of remimazolam during the induction and maintenance of general anesthesia without using a neuromuscular blocking agent (NMBA...
Autores principales: | Park, Insun, Cho, Mincheul, Nam, Sun Woo, Hwang, Jung-Won, Do, Sang-Hwan, Na, Hyo-Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316331/ https://www.ncbi.nlm.nih.gov/pubmed/35883039 http://dx.doi.org/10.1186/s12871-022-01779-2 |
Ejemplares similares
-
General anesthesia using remimazolam and remifentanil in combination with local anesthetics without neuromuscular blocking agents in a patient with myotonic dystrophy
por: Koyama, Yukihide, et al.
Publicado: (2023) -
Remimazolam Compared to Propofol for Total Intravenous Anesthesia with Remifentanil on the Recovery of Psychomotor Function: A Randomized Controlled Trial
por: Shimizu, Takahito, et al.
Publicado: (2023) -
Psychogenic coma after general anesthesia with remimazolam and remifentanil -a case report-
por: Kim, Song Hyun, et al.
Publicado: (2022) -
A retrospective comparative study of anesthesia with remimazolam and remifentanil versus dexmedetomidine and remifentanil for transcatheter aortic valve replacement
por: Kitaura, Atsuhiro, et al.
Publicado: (2023) -
The influence of moderate or deep neuromuscular block status on anesthetic depth monitoring system during total intravenous anesthesia using propofol and remifentanil: A randomized trial
por: Na, Hyo-Seok, et al.
Publicado: (2021)